Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ibrutinib in Steroid Refractory Autoimmune Hemolytic Anemia: ELaboration of Treatment Approach

NCT03827603 is registered in ClinicalTrials.gov with Eugene Nikitin as lead sponsor.

NCT NCT03827603
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03827603 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ibrutinib in Steroid Refractory Autoimmune Hemolytic Anemia: ELaboration of Treatment Approach
Lead sponsor
Eugene Nikitin
Phase
Phase 2
Overall status
Unknown status
Start date
February 21, 2017
Completion date
March 31, 2022
Enrollment
50 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

aiha - warm autoimmune hemolytic anemia